Neonatal Cystic Fibrosis Screening
Alternate Names : Cystic Fibrosis Screening - Neonatal, Immunoreactive Trypsinogen
Definition
Neonatal cystic fibrosis screening involves a pancreatic test that evaluates immunoreactive trypsinogen. The test is performed on newborns to determine whether the baby has cystic fibrosis (CF).
Pictures & Images
See all Pictures & Images
Why is the Test Performed?
Cystic fibrosis is a genetic disease that affects the sweat glands as well as the respiratory and gastrointestinal systems. Trypsinogen is produced by the pancreas and is elevated in babies with cystic fibrosis. This test is a screening tool to identify infants who need further testing to confirm the diagnosis.
|